Anheuser-Busch InBev (BUD)

Consumo básico / Bebidas alcohólicas

The world's largest brewer by volume, with more than double the scale of the second player and the number-one position in three of the industry's five largest profit pools, trades at 20× on underlying earnings growing again at a double-digit rate: It trades close to intrinsic value, far from the required margin of safety. The estimated return is +8% annually and the verdict stands at Fairly valued, with a balance sheet that still carries the debt from the SAB Miller acquisition.

Moat Compounder estimates the intrinsic value of Anheuser-Busch InBev (BUD) at $107 per share on a five-year horizon. With the stock at $80.35 at 2026-09-04 close, the expected total return is 7.8% per year: fairly valued. The analysis draws on 20-F FY2025 and Unaudited interim report — half-year ended Jun-30-2026 (6-K, Jul-30-2026). Analysis dated 2026-07-30.

Price
$80.35
at 2026-09-04 close
Intrinsic value (5y, base)
$107
Total annual return (5y)
7.8%
5.8% price · 2.0% div
Status (nominal)
Fairly valued
Margin of safety
+14%

The essentials

  • Volume leader in more than 30 countries, with 492.6 million hectoliters in 2024 against 241.1 for the second player according to the data the issuer itself cites.
  • The twelve-month window closed on Jun-30-2026 shows revenue of 62,615 million and underlying attributable profit of 8,168 million; the reported profit of 9,327 includes 1,159 million of non-recurring items that are not extrapolated.
  • The 2026 guidance is earnings before interest, taxes, depreciation and amortization growth of between 4% and 8% organic, and year 1 of the path anchors there.
  • Return on invested capital is 7.2%, below the 10% bar, because invested capital carries the price paid across two decades of acquisitions (114,000 million for SAB Miller, 54,800 for Anheuser-Busch, 20,100 for Grupo Modelo).
  • Non-controlling interest takes 19.3% of 2025 consolidated profit —Ambev and Budweiser APAC trade separately—, equivalent to 24.0% of profit attributable to AB InBev's equity holders.
Health: Under watch
Price $80 at 2026-09-04 closeMarket Cap $162.1 bnEnterprise Value $223.4 bnNet debt $61.4 bnP/E (today) 19.8x

Intrinsic value — two valuation methods

Fairly valued
Price market
$80
DCF value today
$118
+46.5% vs price
Multiples value today
$94
+16.7% vs price

Total return at 5 years: 7.9%/year = 5.9% appreciation + 2.0% dividend. The target price ($107) is ex-dividend; the $9 in dividends collected over 5 years are added separately.

By both methods, the value today (DCF $118 · Multiples $94) exceeds the market price ($80).

Pillars of the analysis

The verdict — today vs 5 years

Today — fairly valued: at $80 trades ~14.3% below its value discounted to today (~$94); the discount is positive but does not reach the margin of safety we require (≥38%).

At 5 years — En valor: the target price ($107) plus dividends yield between the 4% floor and the 10% average return — a reasonable return, though without the margin of a great investment.

The bridge: the return at 5 years exceeds the risk-free rate (4.5%) — but the discount does not reach the required margin of safety (≥38%). To require a 15% annual return, it would need to be bought at ~$59.

Thesis

The business

A world leader with more than double the scale of its closest follower, number-one positions in three of the industry's largest markets and a brand portfolio built over decades. Operating quality is high and pricing power is proven: revenue per hectoliter rose 4.3% in the first half of 2026 with organic volume growing 1.1%. What does not keep pace is return on capital, at 7.2%, because the balance sheet carries the price paid across twenty years of mergers.

The valuation

It is valued by a multiple on underlying attributable profit, the correct metric for a leveraged consumer staple: funding cost is already deducted within it and the third-party stake is excluded by construction. On terminal profit in the base case and an exit multiple of 18 times, value per share at five years is $107 against a price of $80. The entry point, today at 20×, compresses to 15× on year-5 profit.

The margin of safety

It trades close to intrinsic value, far from the required margin of safety. The estimated return is +8% annually, of which +6% comes from price appreciation and +2% from the dividend. To require the 15% annual return the method reserves for a great investment, the maximum price to pay today would be -36%. The verdict stands at Fairly valued.

What to watch

The disconfirmer is revenue per hectoliter: the thesis rests on price continuing to rise near four points with volume flat or slightly positive. If the developing-market consumer trades down and that revenue-per-hectoliter figure approaches zero, underlying profit stops growing and the exit multiple has nothing to support it. The second point is leverage: much of the projected profit margin expansion comes from declining financial expense, not from an operating improvement.

Educational / informational. Does not constitute investment advice.

Other companies of the same type